Headline
The latest stories from AHA Today.
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices released its recommendations for the 2020-2021 flu season, which continue to advise yearly flu vaccination for all people aged 6 months and older.
Aug. 30 is the deadline for skilled nursing facilities to preview their quality measure data for the Nursing Home Compare website refresh in October and ask the Centers for Medicare & Medicaid Services to review their data if they believe the scores are inaccurate.
SCA Pharmaceuticals has recalled 10 lots of compounded heparin sodium, an anticoagulant packaged in 500 mL or 1000 mL intravenous bags, the Food and Drug Administration announced.
The Centers for Medicare & Medicaid Services yesterday published guidance for states on the treatment of third party payers in determining the hospital-specific Medicaid disproportionate share hospital payment limits for the state plan rate year 2017 DSH audits.
The AHA urged the Office of Management and Budget to expedite its review and release of final regulations on physician self-referral and the Anti-Kickback Statute that were submitted in July by the Centers for Medicare & Medicaid Services and the Department of Health & Human Services Office…
The Department of Health and Human Services amended the declaration under the Public Readiness and Emergency Preparedness Act to authorize state-licensed pharmacists and pharmacy interns under their supervision to order and administer vaccines to children, subject to certain requirements.
The Centers for Disease Control and Prevention released a study examining how COVID-19 is affecting American Indians and Alaska Natives — one of the populations at highest risk for the disease.
The Food and Drug Administration released a resource to help U.S. health care providers select respirators for their health care facility.
The National Institute for Occupational Safety and Health released a report summarizing the particulate filtration efficiency of non-NIOSH-approved N95 respirators made in other countries and authorized for emergency use during the COVID-19 public health emergency.
The AHA urged President Trump and the Department of Health and Human Services to continue to act on behalf of hospitals and health systems by further expanding telehealth flexibilities.